Literature DB >> 25312343

Thrombosis: a major contributor to global disease burden.

.   

Abstract

Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low, middle and high income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted-life-years (DALYs) lost in low and middle income countries, and second in high income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low, middle, and high income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilization of preventive measures will reduce the burden.
Copyright © 2014 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25312343     DOI: 10.1016/j.thromres.2014.08.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  26 in total

1.  Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.

Authors:  Lauren R Schmitt; Rachel Henderson; Alexander Barrett; Zsuzsanna Darula; Aaron Issaian; Angelo D'Alessandro; Nathan Clendenen; Kirk C Hansen
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

2.  Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.

Authors:  Truman J Milling; Jennifer Frontera
Journal:  Am J Manag Care       Date:  2017-04       Impact factor: 2.229

3.  Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.

Authors:  A Y Mehta; B M Mohammed; E J Martin; D F Brophy; D Gailani; U R Desai
Journal:  J Thromb Haemost       Date:  2016-02-16       Impact factor: 5.824

4.  Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.

Authors:  Elizabeth J Bell; Pamela L Lutsey; Saonli Basu; Mary Cushman; Susan R Heckbert; Donald M Lloyd-Jones; Aaron R Folsom
Journal:  Am J Med       Date:  2015-11-18       Impact factor: 4.965

Review 5.  Apixaban: A Review in Venous Thromboembolism.

Authors:  Sarah L Greig; Karly P Garnock-Jones
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

6.  Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Daniel Douce; Leslie A McClure; Pamela Lutsey; Mary Cushman; Neil A Zakai
Journal:  J Hosp Med       Date:  2017-09-06       Impact factor: 2.960

7.  Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

Authors:  Martin H Prins; Anthonie W A Lensing; Paolo Prandoni; Philip S Wells; Peter Verhamme; Jan Beyer-Westendorf; Rupert Bauersachs; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Ajay K Kakkar; Bonno van Bellen; Akos F Pap; Martin Homering; Miriam Tamm; Jeffrey I Weitz
Journal:  Blood Adv       Date:  2018-04-10

8.  Effectiveness of intraoperative administration of intermittent pneumatic compression in preventing deep vein thrombosis in lung cancer patients undergoing video-assisted thoracoscopic surgery lobectomy.

Authors:  Xiaojun Wang; Saiqi Song; Ruijie Ni; Min Lu; Yanjun Mao
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

9.  A quality improvement project decreases incidence of pulmonary embolism following arthroplasty.

Authors:  Iyad Eid; Dane Moran; Lynn Morrison; Eyad HajHussein; Hanna Hill; Rasha Ansari; Tammy Williams; Mojieb Manzary
Journal:  J Orthop       Date:  2018-02-02

10.  Pulmonary embolism originating from germ cell tumor causes severe left ventricular dysfunction in a healthy young adult with full recovery: a case report.

Authors:  Khaled Elenizi; Rasha Alharthi; Michel Galinier
Journal:  BMC Cardiovasc Disord       Date:  2021-05-26       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.